Tomas Salmonson

The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use

Marta Kollb-Sielecka, Pierre Démolis, Joseph Emmerich et al. · Sleep Medicine · 2017 · 245 citations

Medicine, Pharmacology, Pharmacotherapy +12

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

H‐G Eichler, LG Baird, Richard Barker et al. · Clinical Pharmacology & Therapeutics · 2015 · 187 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +15

European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene

Manuel Haas, Viktor Vlcek, Pavel Balabanov et al. · Neuromuscular Disorders · 2014 · 159 citations

Medicine, Genetics, Neurology +13

The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects.

Tomas Salmonson, BG Danielson, Björn Wíkström · British Journal of Clinical Pharmacology · 1990 · 98 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers.

B. G. Danielson, Tomas Salmonson, Hartmut Derendorf et al. · PubMed · 1996 · 96 citations

Medicine, Clinical Pharmacokinetics, Pharmacokinetics +17